Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNORA8 is a small nucleolar RNA of the H/ACA box class, which typically functions as a guide for pseudouridylation of other RNA molecules, such as ribosomal RNA. It is a non-coding RNA and not considered a protein, receptor, enzyme, transporter, or other classical drug target. There is no evidence that SNORA8 is directly involved in human disease or therapeutically actionable pathways, nor are there known drugs or biomarker roles associated with this molecule at present[1][4]. This target is incorrect for most drug-target purposes—it is an RNA gene, not a receptor, protein, enzyme, or typical therapeutic target. No protein product, molecular family, disease role, drug interaction, or safety concern is documented for ENSG00000207100[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORA8 (SNORA8).